Home › Funds › First Turn Management, LLC › VRDN

First Turn Management, LLC position in VRDN

OBSIDIAN THERAPEUTICS INC · Health Care

First Turn Management, LLC reported holding 1,670,000 shares of VRDN (OBSIDIAN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$30.7M, representing 3.28% of its reported portfolio and ranking #11 among its reported holdings. First Turn Management, LLC has disclosed VRDN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.67M sh
Reported value held$30.68M
Portfolio Weight3.28%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Turn Management, LLC's VRDN position evolved

First Turn Management, LLC first disclosed a stake in VRDN in Q4 2025 at 690,528 shares (US$21.5M). The position peaked in Q2 2026 at 1,670,000 shares, worth US$30.7M. Across 3 filings, First Turn Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,670,000 shares valued at US$30.7M — an increase of 758,663 shares quarter over quarter.. Notable position changes include a 32% increase in Q1 2026 (shares fell 6% over the following quarter), a 83% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 690.53K $21.49M New
Q1 2026 911.34K $17.83M Add
Q2 2026 1.67M $30.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRDN and 13F data

VRDN (OBSIDIAN THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in VRDN — the largest reported positions include Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has First Turn Management, LLC held VRDN?

First Turn Management, LLC has disclosed VRDN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is First Turn Management, LLC's current position in VRDN?

As of Q2 2026, First Turn Management, LLC holds 1.67M shares of VRDN (OBSIDIAN THERAPEUTICS INC), valued at $30.68M, representing 3.28% of its reported portfolio and ranking #11.

Has First Turn Management, LLC been buying or selling VRDN?

In the latest 13F filing (Q2 2026), First Turn Management, LLC increased its position in VRDN. The position peaked in Q2 2026 at 1.67M shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.